All Cancer Microbiology articles – Page 5
-
NewsResearchers advise strengthening immunity against COVID-19 in people with cancer
Researchers who led a study on the effectiveness of vaccines against COVID-19 among cancer patients in Catalonia, have recommended administering additional doses of the vaccine among this risk population.
-
NewsSafer virus helps eliminate cancer and protect against future tumors
Scientists have discovered that an attenuated (weakened) virus can help eliminate cancer in mice. In addition, mice that were treated with this virus were more resistant to developing tumors later in life.
-
NewsEpstein-Barr virus can trigger quicker growth of nasopharyngeal cancer
Scientists have shown how the Epstein-Barr virus (EBV) alters how specific genes are regulated, making nasopharyngeal cancer tumours (NPC) grow faster.
-
NewsLung microbiomes predict mortality in children following bone marrow transplant
Using a method that identifies all potentially pathogenic organisms present in the lungs, scientists have discovered links between certain microbial communities and the relative risk of mortality in children who undergo bone marrow transplants.
-
NewsAntibacterial protein offers new therapeutic target against pancreatic cancer
A recent study describes how pancreatic cancer stem cells take advantage of an antibacterial protein, PGLYRP1, to evade the immune system and protect themselves from early elimination.
-
NewsSpecific microbial hallmarks in vagina could indicate gynecological cancers
A new study demonstrates unique vaginal microbiome in patients with gynecological cancers which could function as a biomarker.
-
NewsNew viral strain induces immunogenic cell death in tumour cells
A study has developed a new strain of vaccinia virus, which can replicate in tumour cells while maintaining increased immunogenicity. Specifically, it can to induce so-called immunogenic cell death in tumour cells.
-
News'Failed drug' could offer new approach to Epstein-Barr virus and resulting diseases
Researchers have found that the Epstein-Barr virus triggers infected cells to ramp up the production of an enzyme known as IDO1, a discovery that offers a promising starting point for putting the brakes on EBV.
-
News HPV testing for cervical cancer may be safe at longer intervals than recommended by current guidelines
The risk of detecting cervical precancer eight years after a negative HPV screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.
-
NewsGut bacteria boost immune response to fight tumors
Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer. Such an approach to beating cancer has seen significant success in lung cancer and melanoma, among others. Optimistic about its potential, researchers are exploring strategies to improve ...
-
NewsScientists make strides in microbiome-based cancer therapies by iron deprivation at the tumor microenvironment
Researchers have made a significant breakthrough in the fight against cancer, exploring a dietary-derived bacterial strain, IMB001, that induces ’nutritional immunity’ to boost anti-tumor responses.
-
NewsHPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows
The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK. Source: NIAID Colorized electron micrograph of HPV virus particles harvested and ...
-
NewsNew method can help scan for new viruses on the horizon
The exchange of genetic material between different virus species can lead to the sudden emergence of threatening pathogens with significantly altered characteristics, new current genetic analyses suggests.
-
NewsPlant virus treatment shows promise in fighting metastatic cancers in mice
An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study.
-
NewsRemoving gut bacteria’s potential ‘safe house’ may lower risk of colorectal cancer subtype
A new study has found an association between appendix removal and a decreased risk of colorectal cancer positive for tumor-promoting bacteria.
-
NewsUS geographic region results in vastly different anal cancer risk for people with HIV
A new study that followed a cohort of more than 110,000 people establishes significant disparities in the risk of anal cancer for people with HIV, depending on the region of the country they live in.
-
NewsTransfected SARS-CoV-2 spike DNA suppresses cancer cell response to chemotherapy
Researchers have examined the interaction between SARS-CoV-2 spike, p53 and MDM2 (E3 ligase, which mediates p53 degradation) in cancer cells using an immunoprecipitation assay.
-
NewsGeologists and biologists unearth atomic fingerprints of cancer using fermenting yeast
Researchers have discovered that cancer cells may be made from a different assortment of hydrogen atoms than healthy tissue, findings which could give doctors new strategies for studying how cancer grows and spreads.
-
NewsNano-drugs hitching a ride on bacteria could help target hard-to-reach pancreatic cancer
Employing bacteria to infiltrate the dense matrix of collagen and other tissues surrounding pancreatic tumors and deliver drugs could aid treatment for pancreatic cancer.
-
NewsGroundbreaking clinical trial evaluates oncolytic virus for non-small cell lung cancer
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer, using a novel oncolytic virus, MEM-288, in combination with the immune checkpoint inhibitor nivolumab.